CC, B., LH, K., M, Z., KA, T., L, S., SM, A., . . . JW, H. (2025). Retraction notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402]. The Journal of pharmacology and experimental therapeutics, 392(4), 103567. https://doi.org/10.1016/j.jpet.2025.103567
Chicago Style (17th ed.) CitationCC, Benoist, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, and Harding JW. "Retraction Notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402]." The Journal of Pharmacology and Experimental Therapeutics 392, no. 4 (2025): 103567. https://doi.org/10.1016/j.jpet.2025.103567.
MLA (9th ed.) CitationCC, Benoist, et al. "Retraction Notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402]." The Journal of Pharmacology and Experimental Therapeutics, vol. 392, no. 4, 2025, p. 103567, https://doi.org/10.1016/j.jpet.2025.103567.